AllianceBernstein’s Immunic IMUX Stock Holding History

AllianceBernstein’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-750	Closed	-$83K	–	3118
2018 Q3	$83K	Buy	+750	New	+$1.96M	﹤0.01%	3094

Other funds holding IMUX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

AllianceBernstein's IMUX Position: Q4 2018 in Review

AllianceBernstein sold out of Immunic (IMUX) in Q4 2018, closing a stake of 824 shares — an estimated $91K sold.

AllianceBernstein first reported a position in IMUX in Q2 2014 and held it in 5 quarters. The position peaked at $105K in Q1 2015. 47 funds tracked by Wall St. Rank hold IMUX as of Q4 2018.

AllianceBernstein reported no remaining Immunic position as of Q4 2018 after selling out during the quarter.
AllianceBernstein sold 824 Immunic shares in Q4 2018, an estimated $91K.
AllianceBernstein first reported a position in Immunic in Q2 2014 and held it in 5 quarters.
AllianceBernstein's Immunic position peaked at $105K in Q1 2015.
47 funds tracked by Wall St. Rank held Immunic as of Q4 2018.

Based on AllianceBernstein's 13F filing for Q4 2018, filed 13 Feb 2019.